PREVENT [phsu]
coronary heart disease [dsyn]
Managed Care [hlca]
Improving [qlco]
Cost Effectiveness [qnco]
Lipid-lowering therapy [topp]
HMG CoA Reductase [aapp, enzy]
inhibitors [chvf]
More [ftcn]
spend [qnco]
Cardiovascular disease [dsyn]
United States [geoa]
GIVEN [cnce]
Cost [qnco]
Awareness [menp]
Managed Care [hlca]
Appropriate [qlco]
Clinical [qlco]
decisions [menp]
Cost Effectiveness [qnco]
treatment [ftcn]
Expenditures [qnco]
Life [idcn]
Save [mcha]
Accepted [qlco]
Cost Effectiveness [qnco]
Lipid-lowering therapy [topp]
Patients [podg]
coronary artery disease [dsyn]
risk factors [qnco]
considered [idcn]
Solid [qlco]
Investment [mnob]
health care resources [qnco]
Data [idcn]
National Health and Nutrition Examination Survey [resa]
III [inpr]
Specific [qlco]
Insight [menp]
disease management [ftcn]
strategies [menp]
Lipid [lipd]
Management [ocac]
Managed Care [hlca]
Patients [podg]
National Health and Nutrition Examination Survey [resa]
III [inpr]
Suggest [idcn]
majority [socb]
Patients [podg]
Elevated Cholesterol [dsyn]
Obtain [ftcn]
Goals [inpr]
national [inpr]
Cholesterol [bacs, strd]
educational program [edac]
Only [qnco]
Moderate [qlco]
reductions [npop]
Low Density Lipoprotein Cholesterol [bacs, strd]
Pharmacologic Management [hlca]
Patients [podg]
Moderate [qlco]
Primary hypercholesterolaemia [dsyn]
synthetic [acty]
HMG-CoA reductase inhibitor [orch, phsu]
fluvastatin [orch, phsu]
considered [idcn]
Preferred [idcn]
Initial [tmco]
Agent [chvf]
Clinical [qlco]
Efficacy [qlco]
Similar [qlco]
Drugs [phsu]
Class [inpr]
Acquisition [acty]
Costs [qnco]
Lower [spco]
Cost Effectiveness [qnco]
